OPEN ACCESS JOURNALS
           
home about us journals search

Journal of General and Molecular Virology

     
   JGMV Home
   About JGMV
   Submit Manuscripts
   Instructions for Authors
   Editors
   Call For Paper
   Archive
   Faculty 1000
   Conferences
   Associations

  J. Gen. Mol. Virol.

 

  Vol. 1 No. 2

  Viewing options:


  •Reprint (PDF) (241k)

  Search Pubmed for articles by:

 Okoror LE
 Momodu IBA


  Other links:
  PubMed Citation
  Related articles in PubMed

Other Journals
African Journal of Agricultural Research
African Journal  of Environmental Science & Technology
Biotechnology & Molecular Biology Reviews

African Journal of Biochemistry Research

African Journal of Microbiology Research
African Journal of Pure & Applied Chemistry
African Journal of Food Science
Journal of Cell & Animal Biology
African Journal of Pharmacy & Pharmacology

African Journal of Biotechnology
Journal of Medicinal Plant Research
International Journal of Physical Sciences
Scientific Research and Essays
 

Journal of General and Molecular Virology Vol. 1 (2), pp.019032, August 2009

© 2009 Academic Journals  

 

Full Length Research Paper

 

 

Functional analysis of lassa virus glycoprotein from a newly identified lassa virus strain for possible use as vaccine using computational methods

 

L. E. Okoror1*, H. A. T. Alaiya2 and I. B. A. Momodu3

 

1Department of Microbiology, Faculty of Natural Sciences, Ambrose Alli University, P. M. B. 14 Ekpoma, Nigeria.

2Department of Biochemistry, Faculty of Natural Sciences, Ambrose Alli University, P. M. B. 14. Ekpoma, Nigeria.

3Department of Computer Sciences, Faculty of Natural Sciences, Ambrose Alli University, P. M. B. 14, Ekpoma, Nigeria.

 

*Corresponding author. E-mail: LEOkoror@gmail.com.

 

Accepted 17 July, 2009.

 

   Abstract

 

Lassa virus is the cause of morbidity and mortality in Ekpoma Nigeria. Recently, two new strains of the virus were identified. The genes were sequenced and deposited in the GenBank. We presume that genes of similar sequence will code for protein of similar function. Hence any vaccine produced using this protein could protect against any other similar virus due to conservation of active and functional regions. The gene codes for a glycoprotein which could be antigenic and stimulate the production of antibody. This is however if the protein could be made non virulence. It then becomes important to have a proper molecular knowledge and function of the protein. Determination of the function of the protein was first by global sequence alignment using blastp with different parameters. However, not all the parameters used produced hits even when e- values were adjusted. Pairwise alignment and multiple sequence alignment (MSA) of the two newly identified proteins were carried out but full analysis of only one of the protein (strain) was done. Other tools used in determining the function of the protein included hydrophobicity, leader sequence, transmembrane helices, Pfam using different tools from expasy and PHD tools. Prints and blocks databases were also searched, but the block database gave no hit. The hidden Markov’s model structure was also done before searching for the 3D structure at PDB using phyre at expasy. The pairwise alignment and MSA were done with clustal W. This study gives a clear function of the lassa virus glycoprotein, and also confirms the stability and antigenicity of the protein so long as multiple domain repeats are carried out before synthesis which will help increase the molecular weight while preserving protein function.

Key words: Lassa virus, multiple sequence alignment, glycoprotein, protein structure, vaccine.

___________________________________________________________________________________________________________

Advertise on JGMV | Terms of Use | Privacy Policy | Help

© Academic Journals 2002 - 2009